Research resource: New and diverse substrates for the insulin receptor isoform a revealed by quantitative proteomics after stimulation with IGF-II or insulin

Molecular Endocrinology

Volumn 25, Issue 8, 2011, Pages 1456-1468

  Morcavallo, Alaide ^a   Gaspari, Marco ^a   Pandini, Giuseppe ^b   Palummo, Angela ^a   Cuda, Giovanni ^a   Larsen, Martin R ^a,c   Vigneri, Riccardo ^b   Belfiore, Antonino ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DISCOIDIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR A; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN BINDING; ISOTOPE LABELING; MASS SPECTROMETRY; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR II; INTRACELLULAR SPACE; ISOTOPE LABELING; MICE; MODELS, BIOLOGICAL; PROTEIN ISOFORMS; PROTEOMICS; RECEPTOR, INSULIN; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 79960986160     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0484     Document Type: Article

References (61)

1. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288
2. Louvi A, Accili D, Efstratiadis A 1997 Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33-48
3. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30:586-623
4. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, Berggren PO 2001 Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol Cell 7:559-570
5. Uhles S, Moede T, Leibiger B, Berggren PO, Leibiger IB 2003 Isoform-specific insulin receptor signaling involves different plasma membrane domains. J Cell Biol 163:1327-1337
6. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP 2001 Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867
7. Sciacca L, Mineo R, Pandini G, Murabito A, Vigneri R, Belfiore A 2002 In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene 21:8240-8250
8. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, Belfiore A 2002 A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245-254
9. Belfiore A 2007 The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 13:671-686
10. Hofmann F, García-Echeverría C 2005 Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today 10:1041-1047
11. Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A 2003 Differential gene expression induced by insulin and insulin like growth factor-II through the insulin receptor isoform A. J Biol Chem 278:42178-42189
12. Pandini G, Conte E, Medico E, Sciacca L, Vigneri R, Belfiore A 2004 IGF-II binding to insulin receptor isoform A induces a par tially different gene expression profile from insulin binding. Ann NY Acad Sci 1028:450-456
13. Sacco A, Morcavallo A, Pandini G, Vigneri R, Belfiore A 2009 Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A. Endocrinology 150:3594-3602
14. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pan-dey A, Mann M 2002 Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376-386
15. Blagoev B, Mann M 2006 Quantitative proteomics to study mito-gen-activated protein kinases. Methods 40:243-250
16. Cohen P 2006 The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol 7:867-873
17. Taniguchi CM, Emanuelli B, Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96
18. Ibarrola N, Molina H, Iwahori A, Pandey A 2004 A novel pro-teomic approach for specific identification of tyrosine kinase substrates using [13C]tyrosine. J Biol Chem 279:15805-15813
19. Schmelzle K, Kane S, Gridley S, Lienhard GE, White FM 2006 Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes 55:2171-2179
20. Wang Y, Li R, Du D, Zhang C, Yuan H, Zeng R, Chen Z 2006 Proteomic analysis reveals novel molecules involved in insulin signaling pathway. J Proteome Res 5:846-855
21. Saeki K, Yasugi E, Okuma E, Breit SN, Nakamura M, Toda T, Kaburagi Y, Yuo A 2005 Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab 289:E419-E428
22. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K 1990 Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J 270:383-390
23. Bailyes EM, Nave BT, Soos MA, Orr SR, Hayward AC, Siddle K 1997 Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J 327(Pt 1):209-215
24. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-39695
25. Jensen M, Hansen B, De Meyts P, Schäffer L, Ursø B 2007 Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. J Biol Chem 282:35179-35186
26. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts Jr CT 2007 Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 27:3569-3577
27. Lim CS, Kim SH, Jung JG, Kim JK, Song WK 2003 Regulation of SPIN90 phosphorylation and interaction with Nck by ERK and cell adhesion. J Biol Chem 278:52116-52123
28. Foti M, Porcheron G, Fournier M, Maeder C, Carpentier JL 2007 The neck of caveolae is a distinct plasma membrane subdomain that concentrates insulin receptors in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 104:1242-1247
29. Lee H, Park DS, Wang XB, Scherer PE, Schwartz PE, Lisanti MP 2002 Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. J Biol Chem 277:34556-34567
30. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shige-matsu S, Bickel PE, Pessin JE, Saltiel AR 2000 CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407:202-207
31. Chang L, Adams RD, Saltiel AR 2002 The TC10-interacting protein CIP4/2 is required for insulin-stimulated Glut4 translocation in 3T3L1 adipocytes. Proc Natl Acad Sci USA 99:12835-12840
32. Murray JT, Campbell DG, Peggie M, Mora A, Cohen P 2004 Identification of filamin C as a new physiological substrate of PKBa using KESTREL. Biochem J 384:489-494
33. Kanzaki M 2006 Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr J 53:267-293
34. Steffen A, Rottner K, Ehinger J, Innocenti M, Scita G, Wehland J, Stradal TE 2004 Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. EMBO J 23:749-759
35. Kim DJ, Kim SH, Lim CS, Choi KY, Park CS, Sung BH, Yeo MG, Chang S, Kim JK, Song WK 2006 Interaction of SPIN90 with the Arp2β complex mediates lamellipodia and actin comet tail formation. J Biol Chem 281:617-625
36. Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P, Siu M, Siminovitch K 2005 Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc Natl Acad Sci USA 102: 1098-1103
37. Innocenti M, Zucconi A, Disanza A, Frittoli E, Areces LB, Steffen A, Stradal TE, Di Fiore PP, Carlier MF, Scita G 2004 Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nat Cell Biol 6:319-327
38. Stuart JR, Gonzalez FH, Kawai H, Yuan ZM 2006 c-Abl interacts with the WAVE2 signaling complex to induce membrane ruffling and cell spreading. J Biol Chem 281:31290-31297
39. Bohil AB, Robertson BW, Cheney RE 2006 Myosin-X is a molecular motor that functions in filopodia formation. Proc Natl Acad Sci USA 103:12411-12416
40. Cox D, Berg JS, Cammer M, Chinegwundoh JO, Dale BM, Cheney RE, Greenberg S 2002 Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat Cell Biol 4:469-477
41. Kizhatil K, Davis JQ, Davis L, Hoffman J, Hogan BL, Bennett V 2007 Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J Biol Chem 282:26552-26561
42. Huber MA, Kraut N, Beug H 2005 Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558
43. Shigeishi H, Fujimoto S, Hiraoka M, Ono S, Taki M, Ohta K, Higashikawa K, Kamata N 2009 Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of micro-tubule-associated protein in human oral squamous cell carcinomas. Int J Oncol 34:1565-1571
44. Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J, Turley EA 2007 The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem 282:16667-16680
45. Maxwell CA, McCarthy J, Turley E 2008 Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci 121:925-932
46. Toole BP, Slomiany MG 2008 Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 18:244-250
47. Vogel WF, Abdulhussein R, Ford CE 2006 Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal 18:1108-1116
48. Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ, Johnson KR 2008 Collagen I-mediated up-regulation of N-cad-herin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol 180:1277-1289
49. Mertins P, Eberl HC, Renkawitz J, Olsen JV, Tremblay ML, Mann M, Ullrich A, Daub H 2008 Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. Mol Cell Proteom-ics 7:1763-1777
50. Luo W, Slebos RJ, Hill S, Li M, Brabek J, Amanchy R, Chaerkady R, Pandey A, Ham AJ, Hanks SK 2008 Global impact of oncogenic Src on a phosphotyrosine proteome. J Proteome Res 7:3447-3460
51. Frisen J, Holmberg J, Barbacid M 1999 Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J 18:5159-5165
52. Vaught D, Brantley-Sieders DM, Chen J 2008 Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. Breast Cancer Res 10:217
53. Licklider LJ, Thoreen CC, Peng J, Gygi SP 2002 Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column. Anal Chem 74:3076-3083
54. Gaspari M, Abbonante V, Cuda G 2007 Gel-free sample preparation for the nanoscale LC-MS/MS analysis and identification of low-nanogram protein samples. J Sep Sci 30:2210-2216
55. Rappsilber J, Ishihama Y, Mann M 2003 Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectros-pray, and LC/MS sample pretreatment in proteomics. Anal Chem 75:663-670
56. Cox J, Mann M 2008 MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and pro-teome-wide protein quantification. Nat Biotechnol 26:1367-1372
57. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C 2009 STRING 8 -a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37:D412-D416
58. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, et al 1985 Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-761
59. White MF 1994 The IRS-1 signaling system. Curr Opin Genet Dev 4:47-54
60. Backer JM, Myers Jr MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J 1992 Phosphati-dylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479
61. Kwon H, Jeong K, Pak Y 2009 Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-depen-dent mitogenesis. J Cell Mol Med 13:1549-1564